DEEPA ABRAHAM: Open Payments
NPI 1760927172 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,965 in 58 payments from 16 companies in 2025. Trend: 2023 $88 · 2024 $549 · 2025 $1,965
Food & beverage: $1,859Education: $106
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $628 |
| AstraZeneca Pharmaceuticals LP | 8 | $318 |
| GlaxoSmithKline, LLC. | 5 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $154 |
| Novartis Pharmaceuticals Corporation | 8 | $147 |
| Lilly USA, LLC | 2 | $135 |
| GENZYME CORPORATION | 1 | $122 |
| Azurity Pharmaceuticals, Inc. | 4 | $82 |
| Amgen Inc. | 2 | $44 |
| ALK-Abello, Inc | 1 | $30 |
Products named: DUPIXENT, FASENRA, NUCALA, EBGLYSS, TEZSPIRE, CUVITRU, ALVESCO, Rhapsido.
Industry payments across TX — which companies pay providers there.
